Executive Team
Mark Schneider
CEO
Mark Schneider earlier career come from a multi-business disciplinary background working for a variety of industries in high-tech and IT developing growth strategies, taking charge of project and turn around management, building distribution networks and developing key accounts.
At the core, his passion for medical device business has always remained, where he started out in anesthesia and intensive care until he then decided to co-found Probingon AB after having worked as strategy consultant. He is the CEO and member of the Board at Probingon.
Robin Augustine
CTO and Owner
Assoc. Prof. Robin Augustine spearheads The Microwaves in Medical Engineering Group (MMG). The MMG is part of the Solid-State Electronics Division of the Department of Electrical Engineering, Uppsala University, Sweden.
His current research field includes designing of microwave sensors, wearable antennas, Bionics, Intrabody communication, Robotics, Machine learning, phantoms, clinical studies, electrophysiology and biological effects of millimeter waves and RF. He is the CTO, Chairman of the Board of Directors and owner of Probingon.
Dr. Mauricio David Pérez
Director R&D
Dr. Mauricio David Pérez received his Engineering degree in Electronics from the National Technological University (UTN) in Argentina in 2007, where he started his journey exploring different applications of microwave technology. He obtained his Ph.D. in Electrical Engineering at the University of Bologna (UNIBO) in Italy in 2012, where he specialized in microwave technology for material characterization. He is an expert in translational research. Currently, he is a senior researcher at the Microwave Medical Engineering Group (MMG) at the Ångström Laboratory, Uppsala University (UU) Sweden, and Director R&D of Probingon AB and member of the board.
Johan Lidén
Member of the board
Johan Lidén has vast experience in the medical device business, with over forty years in different roles working for various disciplines in the sector. Spanning from medical device management and development, IT, and board work to government affairs.
From 1989-2001, he has had P&L responsibility for $50M of international product sales at Siemens Medical, today Getinge. More recently, he had sales responsibility for $100M at Intel corporation. Johan has also successfully served on the board at Camanio care (listed) for three years during the company’s transformation from a product to a product and services company.
His passion for MedTech is also reflected in his engagements within the Swedish Medtech industry group, where he has chaired the Digital health group for several years. He is representing the industry in the national government context.
Johan is an engaged person and is today one of the board members at Probingon AB.
Clinical Advisory Board
Assoc. Prof. Taco. J. Blokhuis
Member of the Advisory board
Dr. Taco J. Blokhuis has been working as a Trauma Surgeon at the MUMC + since 2016. He obtained his PhD cum laude in Amsterdam in 2001 on fracture healing. Dr. Blokhuis lines of research focus in particular on various aspects that are important to non-unions; prevention, treatment and rehabilitation. He is a regular speaker at national and international conferences and is a co-founder of the European Society for Tissue Regeneration in Orthopedics and Traumatology (ESTROT). In addition, as chairman of the Education Committee of the Osteosynthesis and Trauma Care (OTC) foundation, he is closely involved in the training of orthopedic surgeons and general surgeons in the field of fracture treatment.
Assoc. Prof. Afsaneh Koocheck
Member of the Advisory board
Dr. Afsaneh Koochek is a senior lecturer and associate professor in clinical nutrition as well as head of the Department of Food Studies, Nutrition and Dietetics at Uppsala University in Sweden. Moreover, Dr. Koochek possesses a wide and unique combination of national and international experiences as clinical dietician, lecturer, researcher, supervisor, project coordinator and scientific advisor. Her lines of research focus on developing novel nutritional therapies in combination with physical activity for maintenance and/or development of functional health and health related quality of life in aging populations.
Prof. Paul. M. Meaney
Member of the Advisory board
Dr. Paul M. Meaney has extensive industrial experience from working with millimeter-wave technology at both Millitech Corporation, South Deerfield, MA, USA, and Alpha Industries, Woburn, MA. He has been a Professor with Dartmouth College since 1997, with Chalmers University of Technology, Gothenburg, Sweden, and is also the President and Co-Founder of Microwave Imaging System Technologies, Inc., Hanover. He has co-authored over 80 peer-reviewed journal papers and holds 13 patents. His Dartmouth group has authored several clinical studies in various settings including breast cancer diagnosis, breast cancer chemotherapy monitoring, bone density imaging, and temperature monitoring during thermal therapy. His current research interests include microwave tomography, which exploits the many facets of dielectric properties in tissue and other media, and in particular, for breast cancer imaging, where his group was the first to translate an actual system into the clinic.